BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31428091)

  • 1. Regulation of the Complement System by Pentraxins.
    Haapasalo K; Meri S
    Front Immunol; 2019; 10():1750. PubMed ID: 31428091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentraxins in Complement Activation and Regulation.
    Ma YJ; Garred P
    Front Immunol; 2018; 9():3046. PubMed ID: 30619374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTX3 as a paradigm for the interaction of pentraxins with the complement system.
    Inforzato A; Doni A; Barajon I; Leone R; Garlanda C; Bottazzi B; Mantovani A
    Semin Immunol; 2013 Feb; 25(1):79-85. PubMed ID: 23747040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1.
    Roy N; Ohtani K; Hidaka Y; Amano Y; Matsuda Y; Mori K; Hwang I; Inoue N; Wakamiya N
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):1-14. PubMed ID: 27864148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system.
    Ma YJ; Doni A; Skjoedt MO; Honoré C; Arendrup M; Mantovani A; Garred P
    J Biol Chem; 2011 Feb; 286(5):3405-17. PubMed ID: 21106539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.
    Du Clos TW; Mold C
    Curr Opin Organ Transplant; 2011 Feb; 16(1):15-20. PubMed ID: 21150611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern recognition by pentraxins.
    Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A
    Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological actions of pentraxins.
    Vilahur G; Badimon L
    Vascul Pharmacol; 2015 Oct; 73():38-44. PubMed ID: 25962566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to
    Parente R; Possetti V; Erreni M; D'Autilia F; Bottazzi B; Garlanda C; Mantovani A; Inforzato A; Doni A
    Front Immunol; 2021; 12():785883. PubMed ID: 34868070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
    Mantovani A; Garlanda C; Doni A; Bottazzi B
    J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system in Aspergillus fumigatus infections and its crosstalk with pentraxins.
    Parente R; Doni A; Bottazzi B; Garlanda C; Inforzato A
    FEBS Lett; 2020 Aug; 594(16):2480-2501. PubMed ID: 31994174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells.
    Baruah P; Dumitriu IE; Peri G; Russo V; Mantovani A; Manfredi AA; Rovere-Querini P
    J Leukoc Biol; 2006 Jul; 80(1):87-95. PubMed ID: 16617159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxins and atherosclerosis: the role of PTX3.
    Garlanda C; Bottazzi B; Moalli F; Deban L; Molla F; Latini R; Mantovani A
    Curr Pharm Des; 2011; 17(1):38-46. PubMed ID: 21226667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
    Brilland B; Vinatier E; Subra JF; Jeannin P; Augusto JF; Delneste Y
    Front Immunol; 2020; 11():626343. PubMed ID: 33664737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxins in innate immunity: lessons from PTX3.
    Deban L; Jaillon S; Garlanda C; Bottazzi B; Mantovani A
    Cell Tissue Res; 2011 Jan; 343(1):237-49. PubMed ID: 20683616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.
    Csincsi ÁI; Kopp A; Zöldi M; Bánlaki Z; Uzonyi B; Hebecker M; Caesar JJ; Pickering MC; Daigo K; Hamakubo T; Lea SM; Goicoechea de Jorge E; Józsi M
    J Immunol; 2015 May; 194(10):4963-73. PubMed ID: 25855355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte differentiation and macrophage priming are regulated differentially by pentraxins and their ligands.
    Pilling D; Galvis-Carvajal E; Karhadkar TR; Cox N; Gomer RH
    BMC Immunol; 2017 Jun; 18(1):30. PubMed ID: 28619036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation.
    Deban L; Jarva H; Lehtinen MJ; Bottazzi B; Bastone A; Doni A; Jokiranta TS; Mantovani A; Meri S
    J Immunol; 2008 Dec; 181(12):8433-40. PubMed ID: 19050261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.
    Csincsi ÁI; Szabó Z; Bánlaki Z; Uzonyi B; Cserhalmi M; Kárpáti É; Tortajada A; Caesar JJE; Prohászka Z; Jokiranta TS; Lea SM; Rodríguez de Córdoba S; Józsi M
    J Immunol; 2017 Jul; 199(1):292-303. PubMed ID: 28533443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques.
    Pilely K; Fumagalli S; Rosbjerg A; Genster N; Skjoedt MO; Perego C; Ferrante AMR; De Simoni MG; Garred P
    Front Immunol; 2017; 8():1040. PubMed ID: 28900428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.